Empirical Anatomy-Based Ablation vs Emphasize Map-Guided Substrate Ablation in Persistent Atrial Fibrillation : (COMPASS-AF)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorSamsung Medical Center

About this trial

This study is aimed to compare the clinical efficacy of two different catheter ablation strategies in patients with persistent atrial fibrillation.

Participants will be randomized 1:1 into either the Anatomy-based group or the Emphasize map-guided group

* Anatomy-based group : Pulmonary vein isolation (PVI) using pulsed-field ablation (PFA) with a single-shot multielectrode catheter. * Emphasize map-guided group : PVI using radiofrequency (RF) ablation followed by additional EnSite X-guided pathologic substrate modification.

Participants will be followed for 1 year to compare the incidence of any atrial tachyarrhythmia and other clinical parameters between the two groups.

Eligibility criteria

Qualifiers

Adults aged 19 years or older who have voluntarily provided written informed consent to participate in the study

Patients diagnosed with persistent atrial fibrillation (AF) who are scheduled to undergo catheter ablation for AF.

Disqualifiers

History of prior catheter ablation or MAZE surgery for atrial fibrillation.

Left atrial (LA) diameter exceeding 60 mm.

Patients with end-stage renal disease (ESRD).

History of prior open-heart surgery.

Trial design

Treatments tested in this trial

  • Anatomy-based ablation
  • Emphasize map-guided ablation

Treatment groups

360 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Samsung Medical Center

Lead sponsor

Asan Medical Center

Collaborator

Keimyung University Dongsan Medical Center

Collaborator

Korea University Anam Hospital

Collaborator